Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome
Open Access
- 4 November 2023
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (2) , 207.e1-207.e7
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Meteorological Sciences (2021-1-I2M-019)
This publication has 17 references indexed in Scilit:
- Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-AnalysisJournal of Clinical Oncology, 2017
- Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndromeLeukemia, 2017
- High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow TransplantationHaematologica, 2016
- Markedly elevated serum total N-terminal propeptide of type I collagen is a novel marker for the diagnosis and follow up of patients with POEMS syndromeHaematologica, 2014
- New advances in the diagnosis and treatment of POEMS syndromeBritish Journal of Haematology, 2013
- Effective Induction Therapy with Subcutaneous Administration of Bortezomib for Newly Diagnosed POEMS Syndrome: A Case Report and a Review of the LiteratureActa Haematologica, 2012
- Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceBlood, 2012
- Successful Treatment of POEMS Syndrome Complicated by Severe Congestive Heart Failure with ThalidomideInternal Medicine, 2010
- Lenalidomide therapy in a patient with POEMS syndromeBlood, 2007
- A modified peripheral neuropathy scale: the Overall Neuropathy Limitations ScaleJournal of Neurology, Neurosurgery & Psychiatry, 2006